Skip to content

Labor Induction With Double Balloon Device, Oral Misoprostol and Concomitant Use of Both

Labor Induction With Double Balloon Device, Oral Misoprostol and Concomitant Use of Both. Multicenter Randomized Controlled Trial- IDOM Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03866772
Acronym
IDOM
Enrollment
250
Registered
2019-03-07
Start date
2019-06-01
Completion date
2023-09-24
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Related

Keywords

induction of labor, unfavorable cervix, misoprostol, cytotec, double balloon device, cervical ripening

Brief summary

The aim of this study is to compare the rate of cesarean delivery between 3 methods of labor induction: double balloon device, oral misoprostol and combination of the two.

Detailed description

Induction of labor is a common obstetrical procedure. It accounts for 20% of laboring women worldwide. In the past, studies showed that cesarean delivery rates (CDR) are higher in women who are induced. These studies were comparing induction to spontaneous labor, which is not the management in practice, and when the comparison was made between induction and expectant management, the conclusion was that the induction does not increase CDR and can even reduce its' rate. Failure of induction depends on the definition, and even among randomized controlled trials, this definition may vary greatly. The decision whether to use a mechanical or pharmacological agent depends on Bishop score, parity, contraindications to one of the methods and patient-doctor preference. Recently, more data are available regarding induction with oral misoprostol (OM) and this method is becoming more popular because OM is effective, safe, convenient, cheap and easy to administer. If mechanical induction is preferable, either single or double balloon device (DBD) can be used. These methods have been previously studied and neither found to be superior. A recent study showed that, insertion of the DBD for 6 hours in nulliparous women, results in shorter time to delivery (26 hours vs. 31.4 hours, p=0.015), similar Bishop score after removal ( 5.74 vs. 5.26, p=0.2) without increasing the rate of cesarean deliveries (19% vs 32%, p=0.135) when compared to insertion of the DBD for 12 hours as instructed by the manufacturer. Several studies have shown that a combination of pharmacological and single balloon device results in higher rates to achieve vaginal delivery when compared to each method separately The investigators hypothesize that with the combination of DBD for 6 hours and OM we will be able to reduce the rate of cesarean deliveries when compared to each method separately. To date, there are no studies that compared double balloon device with oral misoprostol used concomitantly.

Interventions

50 mcg oral consumption

DEVICEdouble balloon device for cervical ripening

insertion for 6 hours and followed by the above mentioned protocol

Sponsors

Bnai Zion Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* unfavourable cervix (Bishop score ≤ 4), * indication for induction of labor (medical or obstetrical), * 37 completed gestational weeks, * vertex presentation, * singleton pregnancy * intact membranes.

Exclusion criteria

* previous cesarean delivery * previous uterine surgery (eg: myomectomy) * noncephalic presentation * multiple pregnancy * pre-eclampsia with severe features * oligohydramnios (Maximal vertical pocket ≤2) * estimated fetal weight \<10% percentile * any contraindication to Vaginal delivery

Design outcomes

Primary

MeasureTime frameDescription
the rate of cesarean deliveryfrom induction until deliverypercentage of cesarean delivery from all deliveries

Secondary

MeasureTime frameDescription
Bishop score difference between groupsafter 6 hours and after 24 hourscervical change evaluation

Other

MeasureTime frameDescription
Rate of achieving active phase of labor (≥ 5 cm cervical dilatation)within 24 hours of initiationhow many women had more than 5 cm cervical dilatation
Cesarean delivery indication (non progressive labor or non reassuring fetal heart rate NRFHR)from initiation until cesarean deliverywhat was the indication for surgery
Maternal morbidityfrom initiation until deliveryadvanced tears (3rd and 4th degree) post partum hemorrhage uterine rupture, amnionitis
Patient satisfaction - by questionerwithin 5 days from deliveryquestion addressing pain (bearable or unbearable, was the treatment comfortable for the women and would she do it again if necessary
time to deliveryfrom induction to delivery and from ruptured membranes to deliveryMean time to delivery
Neonatal morbidity:within 5 days from deliveryneonatal care unit admission, meconium with\\without fetal heart rate changes, Apgar 5' \<7 ,
use of oxytocinwithin 24 hoursif it was in use at all (yes\\no) and if yes- so for how long (time from initiation until delivery)
use of emergent tocolysisfrom induction until deliveryIV atosiban for tachysystole
how many doses of misoprostolfrom induction until deliverycounting the number of administered doses
tachysystolefrom initiation until deliverymore than 5 contractions in 10 min with or without fetal heart rate changes
Use of other ripening methods after failure of the allocated method24 hours after initiation of the treatmentif the allocated measure was defined as failed after 24 hours, other methods will be used to ripen the cervix.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 14, 2026